ProHance (BRACCO DIAGNOSTICS INC)
Welcome to the PulseAid listing for the ProHance drug offered from BRACCO DIAGNOSTICS INC. This Magnetic Resonance Contrast Activity [MoA],Paramagnetic Contrast Agent [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | BRACCO DIAGNOSTICS INC |
| NON-PROPRIETARY NAME: | gadoteridol |
| SUBSTANCE NAME: | GADOTERIDOL |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Magnetic Resonance Contrast Activity [MoA],Paramagnetic Contrast Agent [EPC] |
| ROUTE: | INTRAVENOUS |
| DOSAGE FORM: | INJECTION, SOLUTION |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 1992-11-16 |
| END MARKETING DATE: | 0000-00-00 |
ProHance HUMAN PRESCRIPTION DRUG Details:
| Item Description | ProHance from BRACCO DIAGNOSTICS INC |
| LABELER NAME: | BRACCO DIAGNOSTICS INC |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 279.3(mg/mL) |
| START MARKETING DATE: | 1992-11-16 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0270-1111_af96951b-3335-4f89-b474-0423bc93b813 |
| PRODUCT NDC: | 0270-1111 |
| APPLICATION NUMBER: | NDA020131 |
Other GADOTERIDOL Pharmaceutical Manufacturers / Labelers:
